Mark  Christianson net worth and biography

Mark Christianson Biography and Net Worth

In excess of 15 years of executive sales, sales management, marketing, and project management experience with development stage companies. Prior to NeuroOne, Mr. Christianson held the positions of North American Sales Manager for Cortec Corporation, a manufacturer of specialty chemical products, and Regional Sales Manager for PMT Corporation, a leading manufacturer of products for neurosurgery, orthopedics and plastic surgery. He holds an accounting degree from Augsburg College.

What is Mark Christianson's net worth?

The estimated net worth of Mark Christianson is at least $156.86 thousand as of March 12th, 2026. Mr. Christianson owns 214,383 shares of NeuroOne Medical Technologies stock worth more than $156,864 as of April 10th. This net worth estimate does not reflect any other assets that Mr. Christianson may own. Learn More about Mark Christianson's net worth.

How do I contact Mark Christianson?

The corporate mailing address for Mr. Christianson and other NeuroOne Medical Technologies executives is 10006 Liatris Ln, EDEN PRAIRIE, MN 55347-1210, United States. NeuroOne Medical Technologies can also be reached via phone at (952) 426-1383 and via email at [email protected]. Learn More on Mark Christianson's contact information.

Has Mark Christianson been buying or selling shares of NeuroOne Medical Technologies?

Mark Christianson has not been actively trading shares of NeuroOne Medical Technologies during the last ninety days. Most recently, Mark Christianson sold 100 shares of the business's stock in a transaction on Friday, March 13th. The shares were sold at an average price of $0.80, for a transaction totalling $80.00. Following the completion of the sale, the director now directly owns 214,283 shares of the company's stock, valued at $171,426.40. Learn More on Mark Christianson's trading history.

Are insiders buying or selling shares of NeuroOne Medical Technologies?

During the last year, NeuroOne Medical Technologies insiders bought shares 1 times. They purchased a total of 1,000,000 shares worth more than $670,000.00. During the last year, insiders at the sold shares 7 times. They sold a total of 53,618 shares worth more than $39,478.24. The most recent insider tranaction occured on March, 13th when Director Mark Christianson sold 100 shares worth more than $80.00. Insiders at NeuroOne Medical Technologies own 11.8% of the company. Learn More about insider trades at NeuroOne Medical Technologies.

Information on this page was last updated on 3/13/2026.

Mark Christianson Insider Trading History at NeuroOne Medical Technologies

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/13/2026Sell100$0.80$80.00214,283View SEC Filing Icon  
3/12/2026Sell817$0.80$653.60214,383View SEC Filing Icon  
3/11/2026Sell2,109$0.80$1,687.20215,200View SEC Filing Icon  
3/10/2026Sell11,611$0.80$9,288.80217,309View SEC Filing Icon  
9/5/2025Sell30,000$0.74$22,200.00231,238View SEC Filing Icon  
5/22/2025Sell8,967$0.62$5,559.54271,491View SEC Filing Icon  
5/21/2025Sell14$0.65$9.10280,458View SEC Filing Icon  
6/5/2024Sell25,800$0.88$22,704.00297,224View SEC Filing Icon  
12/26/2023Sell6,848$1.35$9,244.80332,039View SEC Filing Icon  
12/21/2023Sell9,907$1.40$13,869.80340,687View SEC Filing Icon  
3/23/2023Sell12,711$1.50$19,066.50337,494View SEC Filing Icon  
3/21/2023Sell2,122$1.60$3,395.20361,872View SEC Filing Icon  
6/23/2021Sell11,300$6.74$76,162.001,077,906View SEC Filing Icon  
See Full Table

Mark Christianson Buying and Selling Activity at NeuroOne Medical Technologies

This chart shows Mark Christianson's buying and selling at NeuroOne Medical Technologies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

NeuroOne Medical Technologies Company Overview

NeuroOne Medical Technologies logo
NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders. It also fucuses on applications for other areas, such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.
Read More

Today's Range

Now: $0.73
Low: $0.72
High: $0.75

50 Day Range

MA: $0.76
Low: $0.67
High: $0.86

2 Week Range

Now: $0.73
Low: $0.44
High: $1.16

Volume

49,188 shs

Average Volume

136,692 shs

Market Capitalization

$36.97 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.63